MedTrace Logo

Pharmacokinetics of Testosterone Lotion in the Treatment of Hypogonadal Males

NCT00372008 · Status: COMPLETED · Phase: PHASE2 · Type: INTERVENTIONAL · Enrollment: 40

Last updated 2008-06-20

No results posted yet for this study

Summary

Testosterone replacement treatment is the most effective way of treating hypogonadism in men. Acrux has a proprietry testosterone replacement product - Testosterone-MD Lotion, and this study will evaluate the efficacy and safety of this product.

Conditions

  • Hypogonadism

Interventions

DRUG

Testosterone

Sponsors & Collaborators

  • Acrux DDS Pty Ltd

    lead INDUSTRY

Principal Investigators

  • Tina Soulis, PhD · Acrux Ltd

Study Design

Allocation
RANDOMIZED
Masking
NONE
Model
CROSSOVER

Eligibility

Min Age
18 Years
Max Age
70 Years
Sex
MALE
Healthy Volunteers
No

Timeline & Regulatory

Start
2006-10-31
Primary Completion
2007-04-30
Completion
2007-04-30

Countries

  • United States

Study Locations

More Related Trials

Read the full study record

This page highlights key information. For complete eligibility criteria, study locations, investigator contacts, and the full protocol, visit the original record on ClinicalTrials.gov.

View NCT00372008 on ClinicalTrials.gov